What is Test n Share?
Test n Share operates at the intersection of chronic disease management and digital health innovation. The company provides a robust ecosystem for managing diabetic patients, utilizing remote monitoring technology and sophisticated patient engagement tools. By integrating seamlessly with Bluetooth-enabled hardware, the platform offers healthcare providers a centralized clinical care portal that simplifies complex data streams. Beyond clinical utility, the firm addresses the corporate sector by offering wellness management programs designed to optimize workforce productivity and mitigate the rising costs associated with diabetes care. This dual-pronged approach—serving both clinical providers and enterprise employers—establishes Test n Share as a versatile player in the health-tech sector, focused on improving long-term patient outcomes through data-driven interventions.
How much funding has Test n Share raised?
Test n Share has raised a total of $31K across 1 funding round:
Debt
$31K
Debt (2021): $31K with participation from PPP
Key Investors in Test n Share
PPP
Public-Private Partnership
What's next for Test n Share?
With the recent influx of capital, Test n Share is expected to prioritize the scaling of its remote monitoring infrastructure and the expansion of its enterprise wellness offerings. The strategic roadmap likely includes enhancing the interoperability of its clinical portal to support broader health system integrations and investing in advanced analytics to further personalize patient care pathways. As the company navigates this significant Series B/C stage, the focus will remain on demonstrating measurable ROI for employer clients and clinical efficacy for healthcare providers. Future growth will likely be driven by increased adoption of its digital tools, potentially leading to further market consolidation or strategic partnerships within the broader healthcare technology ecosystem.
See full Test n Share company page
